Amarin Corp Plcuk (AMRN) Gains from Investment Securities (2011 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Gains from Investment Securities of -$56000.0 for Q1 2026, down 105.0% YoY from $1.1 million in Q1 2025, and down 460.0% sequentially from -$10000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Gains from Investment Securities (2011 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Gains from Investment Securities across 16 years of filings, most recently posting -$56000.0 for Q1 2026.

  • In Q1 2026, Gains from Investment Securities fell 105.0% year-over-year to -$56000.0; the TTM figure through Mar 2026 stood at $2.7 million (down 36.63% YoY), while the FY2025 annual figure was $4.1 million, down 85.33% from the prior year.
  • Gains from Investment Securities declined to -$56000.0 in Q1 2026, from -$10000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for AMRN reached as high as $30.8 million in Q3 2025 and fell as low as -$56000.0 in Q1 2026.
  • The 5-year median for Gains from Investment Securities is $851549.0 (2023), against an average of $2.6 million.
  • Annual changes were most pronounced in 2024 — Gains from Investment Securities jumped 18611.11% — and 2026, when it plunged 105.0%.
  • A 5-year view of Gains from Investment Securities shows it stood at $2.5 million in 2022, then tumbled by 99.64% to $9000.0 in 2023, then jumped by 18611.11% to $1.7 million in 2024, then tumbled by 100.59% to -$10000.0 in 2025, then tumbled by 460.0% to -$56000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered -$56000.0, -$10000.0, and $30.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.82 Mn
Mar 31, 2026 30.82 Mn
Dec 31, 2025 -10,000.00
Dec 31, 2025 -10,000.00
Sep 30, 2025 30.77 Mn
Sep 30, 2025 30.77 Mn
Jun 30, 2025 750,000.00
Jun 30, 2025 750,000.00
Mar 31, 2025 1.69 Mn
Mar 31, 2025 1.69 Mn
Dec 31, 2024 1.68 Mn
Dec 31, 2024 1.68 Mn
Sep 30, 2024 227,380.00
Sep 30, 2024 227,380.00
Jun 30, 2024 1.09 Mn
Jun 30, 2024 1.09 Mn
Mar 31, 2024 -36,000.00
Mar 31, 2024 -36,000.00
Dec 31, 2023 9,000.00
Dec 31, 2023 9,000.00